253 related articles for article (PubMed ID: 16042366)
1. Somatopause reflects age-related changes in the neural control of GH/IGF-I axis.
Giordano R; Lanfranco F; Bo M; Pellegrino M; Picu A; Baldi M; Balbo M; Bonelli L; Grottoli S; Ghigo E; Arvat E
J Endocrinol Invest; 2005; 28(3 Suppl):94-8. PubMed ID: 16042366
[TBL] [Abstract][Full Text] [Related]
2. Is the somatopause an indication for growth hormone replacement?
Savine R; Sönksen PH
J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
[TBL] [Abstract][Full Text] [Related]
3. Associated hormonal decline in aging: is there a role for GH therapy in aging men?
Lombardi G; Di Somma C; Rota F; Colao A
J Endocrinol Invest; 2005; 28(3 Suppl):99-108. PubMed ID: 16042367
[TBL] [Abstract][Full Text] [Related]
4. The somatopause: should growth hormone deficiency in older people Be treated?
Lieberman SA; Hoffman AR
Clin Geriatr Med; 1997 Nov; 13(4):671-84. PubMed ID: 9354748
[TBL] [Abstract][Full Text] [Related]
5. Somatopause: dismetabolic and bone effects.
Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A
J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721
[TBL] [Abstract][Full Text] [Related]
6. Human aging and the GH-IGF-I axis.
Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
[TBL] [Abstract][Full Text] [Related]
7. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
Lee KO; Liao L; Mukherjee JJ
Mech Ageing Dev; 2004 Apr; 125(4):291-5. PubMed ID: 15063105
[TBL] [Abstract][Full Text] [Related]
8. [Somatopause: the present state-of-art].
Krysiak R; Kedzia A; Okopień B
Wiad Lek; 2009; 62(1):52-61. PubMed ID: 19817258
[TBL] [Abstract][Full Text] [Related]
9. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
10. Somatopause: state of the art.
Di Somma C; Brunelli V; Savanelli MC; Scarano E; Savastano S; Lombardi G; Colao A
Minerva Endocrinol; 2011 Sep; 36(3):243-55. PubMed ID: 22019753
[TBL] [Abstract][Full Text] [Related]
11. The somatopause is no indication for growth hormone therapy.
von Werder K
J Endocrinol Invest; 1999; 22(5 Suppl):137-41. PubMed ID: 10442583
[TBL] [Abstract][Full Text] [Related]
12. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
Devin JK; Young PP
Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
[TBL] [Abstract][Full Text] [Related]
13. GHRH and GH secretagogues: clinical perspectives and safety.
Aimaretti G; Baldelli R; Corneli G; Bellone S; Rovere S; Croce C; Ragazzoni F; Giordano R; Arvat E; Bona G; Ghigo E
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():86-92. PubMed ID: 16456487
[TBL] [Abstract][Full Text] [Related]
14. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding.
Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S
Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484
[TBL] [Abstract][Full Text] [Related]
15. Ageing, growth hormone and physical performance.
Lanfranco F; Gianotti L; Giordano R; Pellegrino M; Maccario M; Arvat E
J Endocrinol Invest; 2003 Sep; 26(9):861-72. PubMed ID: 14964439
[TBL] [Abstract][Full Text] [Related]
16. Update on new therapeutic options for the somatopause.
Ceda GP; Dall'Aglio E; Morganti S; Denti L; Maggio M; Lauretani F; Andrea A; Ceresini G; Cattabiani C; Valenti G
Acta Biomed; 2010; 81 Suppl 1():67-72. PubMed ID: 20518193
[TBL] [Abstract][Full Text] [Related]
17. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.
Thorner MO
J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1039-44. PubMed ID: 19587105
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
[TBL] [Abstract][Full Text] [Related]
19. The role of the GH/IGF-I axis for cardiac function and structure.
Isgaard J; Tivesten A; Friberg P; Bengtsson BA
Horm Metab Res; 1999; 31(2-3):50-4. PubMed ID: 10226781
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
